Synopsis and synthesis of candidate-gene association studies in chronic lymphocytic leukemia: The CUMAGAA-CLL information system

American Journal of Epidemiology

Volumn 170, Issue 6, 2009, Pages 671-678

  Zintzaras, Elias ^a,b   Kitsios, George D ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Database; Epidemiology; Genes; Genome, human; Information systems; Leukemia, lymphocytic, chronic, B cell; Meta analysis; Polymorphism, genetic

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GLUTATHIONE TRANSFERASE M1; INTERLEUKIN 10; LYMPHOTOXIN; PROTEIN BAX; PURINERGIC P2X RECEPTOR; TUMOR NECROSIS FACTOR;

DISEASE INCIDENCE; ETIOLOGY; GENE EXPRESSION; GENETIC VARIATION; GENOME; HETEROGENEITY; INFORMATION SYSTEM; META-ANALYSIS; RESEARCH PROGRAM; STATISTICAL ANALYSIS; TUMOR;

ARTICLE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC MODEL; GENETIC VARIABILITY; HUMAN; INFORMATION SYSTEM;

CONFIDENCE INTERVALS; DATABASES, FACTUAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERNET; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; ODDS RATIO; RISK ASSESSMENT;

EID: 69949114882     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp201     Document Type: Article

References (49)

1. Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61(7):634-645. (Pubitemid 351766746)
2. Slager SL, Kay NE, Fredericksen ZS, et al. Susceptibility genes and B-chronic lymphocytic leukaemia. Br J Haematol. 2007;139(5):762-771.
3. Goldin LR, Caporaso NE. Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours. Br J Haematol. 2007; 139(5):774-779. (Pubitemid 350119794)
4. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17(12):3835-3849.
5. Zintzaras E, Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet. 2008;53(1):1-9.
6. Yu W, Wulf A, Liu T, et al. Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases [electronic article]. BMC Bioinformatics. 2008;9:528.
7. Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1): 308-311. (Pubitemid 32054478)
8. Thorisson GA, Smith AV, Krishnan L, et al. The International HapMap Project Web site. Genome Res. 2005;15(11): 1592-1593. (Pubitemid 41545013)
9. Maglott D, Ostell J, Pruitt KD, et al. Entrez Gene: genecentered information at NCBI. Nucleic Acids Res. 2007; 35(database issue):D26-D31. (Pubitemid 46056164)
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3): 177-188.
11. Harbord RM, Egger M, Sterne JA. A modified test for smallstudy effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443-3457. (Pubitemid 44575162)
12. Skogsberg S, Tobin G, Kröber A, et al. The G(-248)A polymorphism in the promoter region of the Box gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia. 2006;20(1):77-81.
13. Saxena A, Moshynska O, Sankaran K, et al. Association of a novel single nucleotide polymorphism, G(-248)A, in the 5'-UTR of BAX gene in chronic lymphocytic leukemia with disease progression and treatment resistance. Cancer Lett. 2002; 187(1-2): 199-205. (Pubitemid 35279350)
14. Starczynski J, Pepper C, Pratt G, et al. Common polymorphism G(-248)A in the promoter region of the box gene results in significantly shorter survival in patients with chronic lymphocytic leukemia once treatment is initiated. J Clin Oncol. 2005;23(7): 1514-1521. (Pubitemid 46260040)
15. Nückel H, Frey UH, Sellmann L, et al. Box gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progressionfree survival [letter]. Leukemia. 2006;20(4):724.
16. Gra QA, Glotov AS, Nikitin EA, et al. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients. Am J Hematol. 2008;83(4):279-287.
17. Yuille M, Condie A, Hudson C, et al. Relationship between glutathione 5-transferase Ml, Tl, and Pl polymorphisms and chronic lymphocytic leukemia. Blood. 2002;99(11): 4216-4218. (Pubitemid 35332068)
18. Tsabouri S, Georgiou I, Katsaraki A, et al. Glutathione sulfur transferase Ml and Tl genotypes in chronic lymphoblastic leukemia. Hematol J. 2004;5(6):500-504. (Pubitemid 40045284)
19. Lemos MC, Cabrita FJ, Silva HA, et al. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis. 1999;20(7): 1225-1229.
20. Chiu BC, Kolar C, Gapstur SM, et al. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study. Br J Haematol. 2005; 128(5):610-615. (Pubitemid 40343229)
21. Guzowski D, Chandrasekaran A, Gawel C, et al. Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J. Biomol Tech. 2005; 16(2): 154-166.
22. Wang SS, Cerhan JR, Hartge P, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res. 2006;66(19): 9771-9780. (Pubitemid 44623679)
23. Nieters A, Beckmann L, Deeg E, et al. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun. 2006;7(8): 615-624. (Pubitemid 46242365)
24. Ennas MG, Moore PS, Zueca M, et al. Interleukin-IB (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol. 2008;26(2):98-103.
25. Mainou-Fowler T, Dickinson AM, Taylor PR, et al. Tumour necrosis factor gene polymorphisms in lymphoproliferative disease. Leuk Lymphoma. 2000;38(5-6):547-552. (Pubitemid 30614540)
26. Demeter J, Porzsolt F, Rämisch S, et al. Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia. Br J Haematol. 1997;97(1): 107-112. (Pubitemid 27179570)
27. Jevtovic-Stoimenov T, Kocic G, Pavlovic D, et al. Polymorphisms of tumor-necrosis factor-α-308 and lymphotoxin-α + 250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells. Leuk Lymphoma. 2008;49(11):2163-2169.
28. Lim U, Wang SS, Hartge P, et al. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood. 2007;109(7):3050-3059. (Pubitemid 46482106)
29. Rudd MF, Sellick GS, Allinson R, et al. MTHFR polymorphisms and risk of chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2268-2270. (Pubitemid 40054328)
30. Nückel H, Frey UH, Dürig J, et al. Methylenetetrahydrofolate reductase (MTHFR) gene 677C>Tand 1298A >C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia. Leukemia. 2004;18(11):1816-1823. (Pubitemid 39530011)
31. Zhang LY, Ibbotson RE, Orchard JA, et al. P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12. Leukemia. 2003; 17( 11):2097-2100.
32. Thunberg U, Tobin G, Johnson A, et al. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet. 2002;360(9349):1935- 1939. (Pubitemid 35472135)
33. Starczynski J, Pepper C, Pratt G, et al. The P2X7 receptor gene polymorphism 1513 A->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia. Br J Haematol. 2003;123(1):66-71. (Pubitemid 37222759)
34. Sellick GS, Rudd M, Eve P, et al. The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2004;13(6):1065-1067. (Pubitemid 38756719)
35. Wiley JS, Dao-Ung LP, Gu BJ, et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet. 2002;359(9312): 1114-1119.
36. Nückel H, Frey UH, Dürig J, et al. 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome. Eur J Haematol. 2004;72(4):259-263. (Pubitemid 38406557)
37. Dao-Ung LP, Fuller SJ, Sluyter R, et al. Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia. Br J Haematol. 2004; 125(6): 815-817. (Pubitemid 38813610)
38. Cabrini G, Falzoni S, Forchap SL, et al. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol. 2005; 175(1):82-89. (Pubitemid 40884304)
39. Wihlborg C, Sjöberg J, Intaglietta M, et al. Tumour necrosis factor-alpha cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia. Br J Haematol. 1999; 104(2):346-349. (Pubitemid 29083344)
40. Au WY, Fung A, Wong KF, et al. Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population. Leuk Lymphoma. 2006;47(10):2189-2193. (Pubitemid 44650097)
41. Bogunia-Kubik K, Mazur G, Urbanowicz I, et al. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia. Int J Immunogenet. 2006;33(1):21-24.
42. Rawstron AC, Green MJ, Kuzmicki A, et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100(2):635-639.
43. Manolio TA, Rodriguez LL, Brooks L, et al. New models of collaboration in genome-wide association studies: the Genetic Association Information Network. GAIN Collaborative Research Group. Nat Genet. 2007;39(9): 1045-1051.
44. Kitsios G, Zintzaras E. Genetic variation associated with ischemic heart failure: a HuGE review and meta-analysis. Am J Epidemiol. 2007;166(6):619-633. (Pubitemid 47347896)
45. Nguyen DT, Diamond LW, Schwonzen M, et al. Chronic lymphocytic leukemia with an interfollicular architecture: avoiding diagnostic confusion with monocytoid B-cell lymphoma. Leuk Lymphoma. 1995 ; 18( 1 -2): 179-184.
46. McCarron KF, Hammel JP, Hsi ED. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders. Am J Clin Pathol. 2000;113(6):805-813.
47. Cordell HJ. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet. 2002;11(20):2463- 2468.
48. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet. 2001 ;358(9290):1356-1360. (Pubitemid 33016504)
49. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008; 40(10): 1204-1210.